What is CareDx's remainder of 2026?

CareDx (CDNA) reported remainder of 2026 of $4.11M in Q1 2026.

How has CareDx's remainder of 2026 changed year-over-year?

CareDx's remainder of 2026 decreased by 12.7% year-over-year, from $4.71M to $4.11M.

CareDx CDNA Remainder of 2026

Remainder of 2026 at other companies

Natera, Inc.NTRA

——

NeoGenomicsNEO

——

VeracyteVCYT

——

Guardant HealthGH

——

Agilent TechnologiesA

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

See full

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

See full

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

See full

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

See full

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's remainder of 2026.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CareDx's remainder of 2026?: CareDx (CDNA) reported remainder of 2026 of $4.11M in Q1 2026.
How has CareDx's remainder of 2026 changed year-over-year?: CareDx's remainder of 2026 decreased by 12.7% year-over-year, from $4.71M to $4.11M.